Avestar Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Avestar Capital's MRNA Position: Q3 2026 in Review
Avestar Capital opened a new position in Moderna (MRNA) in Q3 2026: 2,369 shares worth $456K. The stake represents 0.04% of the portfolio and ranks #379 among its holdings. This is a return to the name: Avestar Capital previously reported a position in MRNA as recently as Q2 2024.
Avestar Capital first reported a position in MRNA in Q3 2020 and has held it in 10 quarters since. The position peaked at $2.42M in Q3 2021. 1,044 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Avestar Capital held 2,369 shares of Moderna worth $456K as of Q3 2026.
- Moderna was a new Avestar Capital position in Q3 2026.
- Moderna made up 0.04% of Avestar Capital's portfolio in Q3 2026, its #379 holding.
- Avestar Capital first reported a position in Moderna in Q3 2020 and has held it in 10 quarters since.
- Avestar Capital's Moderna position peaked at $2.42M in Q3 2021.
- 1,044 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Avestar Capital's 13F filing for Q3 2026, filed 28 Oct 2026.